{"transactions":[{"id":760696,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock , $0.001 par value","published_at":"2026-05-29T00:15:59.000Z","date":"2026-05-27","kind":"purchase","planned":false,"acquired":true,"shares":4500,"price":1.0708,"value":4818.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":62514,"source":{"system":"sec-edgar","filing":"0001193125-26-245832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000119312526245832/ownership.xml","form_type":"4"}},{"id":760695,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock , $0.001 par value","published_at":"2026-05-29T00:15:59.000Z","date":"2026-05-26","kind":"purchase","planned":false,"acquired":true,"shares":23190,"price":1.0552,"value":24470.088,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":58014,"source":{"system":"sec-edgar","filing":"0001193125-26-245832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000119312526245832/ownership.xml","form_type":"4"}},{"id":760694,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock , $0.001 par value","published_at":"2026-05-29T00:15:59.000Z","date":"2026-05-22","kind":"purchase","planned":false,"acquired":true,"shares":15950,"price":1.0475,"value":16707.625,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":34824,"source":{"system":"sec-edgar","filing":"0001193125-26-245832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000119312526245832/ownership.xml","form_type":"4"}},{"id":760693,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock , $0.001 par value","published_at":"2026-05-29T00:15:59.000Z","date":"2026-05-21","kind":"purchase","planned":false,"acquired":true,"shares":3420,"price":1.0422,"value":3564.324,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":18874,"source":{"system":"sec-edgar","filing":"0001193125-26-245832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000119312526245832/ownership.xml","form_type":"4"}},{"id":780690,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-13T12:47:13.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 8, 2026. The 25% of the shares underlying the option are scheduled to vest on May 8, 2027 and thereafter in equal monthly installments through May 8, 2031."}],"balance_after":150000,"derivative":{"exercise_price":1.17,"expiration_date":"2036-05-08","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001193125-26-220718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312526220718/ownership.xml","form_type":"4"}},{"id":780689,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common stock , $0.001 par value","published_at":"2026-05-13T12:47:13.000Z","date":"2026-04-30","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in Issuer's April 30, 2026 follow-on public offering."}],"balance_after":27046,"source":{"system":"sec-edgar","filing":"0001193125-26-220718","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312526220718/ownership.xml","form_type":"4"}},{"id":996919,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":18161,"kind":"organization","name":"Voss Capital, LP","position":1,"cik":"0001730145","reported_name":"Voss Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18162,"kind":"organization","name":"Voss Value Master Fund, LP","position":2,"cik":"0001969435","reported_name":"Voss Value Master Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18163,"kind":"organization","name":"Voss Value-Oriented Special Situations Fund, LP","position":3,"cik":"0001863498","reported_name":"Voss Value-Oriented Special Situations Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18164,"kind":"organization","name":"Voss Advisors GP, LLC","position":4,"cik":"0001798309","reported_name":"Voss Advisors GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18165,"kind":"person","name":"Cocke Travis W.","position":5,"cik":"0001798383","reported_name":"Cocke Travis W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2025-11-18T22:30:44.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":104183,"price":1.2247,"value":127592.9201,"ownership":{"direct":false,"nature":"By: Voss Value Master Fund, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed jointly by Voss Value Master Fund, LP (\"Voss Value Master Fund\"), Voss Value-Oriented Special Situations Fund, LP (\"Voss Value-Oriented Special Situations Fund\"), Voss Advisors GP, LLC (\"Voss GP\"), Voss Capital, LP (\"Voss Capital\") and Travis W. Cocke (collectively, the \"Reporting Persons\"). Each of the Reporting Persons is a member of a group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, that collectively beneficially owns over 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.1800 to $1.2500, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned directly by Voss Value Master Fund. Voss GP, as the general partner of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Voss Capital, as the investment manager of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund."}],"balance_after":926441,"source":{"system":"sec-edgar","filing":"0000921895-25-003156","document":"form410925019_11182025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863498/000092189525003156/form410925019_11182025.xml","form_type":"4"}},{"id":1012915,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":18161,"kind":"organization","name":"Voss Capital, LP","position":1,"cik":"0001730145","reported_name":"Voss Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18162,"kind":"organization","name":"Voss Value Master Fund, LP","position":2,"cik":"0001969435","reported_name":"Voss Value Master Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18163,"kind":"organization","name":"Voss Value-Oriented Special Situations Fund, LP","position":3,"cik":"0001863498","reported_name":"Voss Value-Oriented Special Situations Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18164,"kind":"organization","name":"Voss Advisors GP, LLC","position":4,"cik":"0001798309","reported_name":"Voss Advisors GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18165,"kind":"person","name":"Cocke Travis W.","position":5,"cik":"0001798383","reported_name":"Cocke Travis W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2025-10-28T22:45:45.000Z","date":"2025-10-28","kind":"purchase","planned":false,"acquired":true,"shares":178392,"price":1.39,"value":247964.88,"ownership":{"direct":false,"nature":"By: Voss Value-Oriented Special Situations Fund, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed jointly by Voss Value Master Fund, LP (\"Voss Value Master Fund\"), Voss Value-Oriented Special Situations Fund, LP (\"Voss Value-Oriented Special Situations Fund\"), Voss Advisors GP, LLC (\"Voss GP\"), Voss Capital, LP (\"Voss Capital\") and Travis W. Cocke (collectively, the \"Reporting Persons\"). Each of the Reporting Persons is a member of a group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, that collectively beneficially owns over 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities owned directly by Voss Value-Oriented Special Situations Fund. Voss GP, as the general partner of Voss Value-Oriented Special Situations Fund, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund. Voss Capital, as the investment manager of Voss Value-Oriented Special Situations Fund, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund."}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0000921895-25-002819","document":"form410925019_10282025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863498/000092189525002819/form410925019_10282025.xml","form_type":"4"}},{"id":1012914,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":18161,"kind":"organization","name":"Voss Capital, LP","position":1,"cik":"0001730145","reported_name":"Voss Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18162,"kind":"organization","name":"Voss Value Master Fund, LP","position":2,"cik":"0001969435","reported_name":"Voss Value Master Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18163,"kind":"organization","name":"Voss Value-Oriented Special Situations Fund, LP","position":3,"cik":"0001863498","reported_name":"Voss Value-Oriented Special Situations Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18164,"kind":"organization","name":"Voss Advisors GP, LLC","position":4,"cik":"0001798309","reported_name":"Voss Advisors GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18165,"kind":"person","name":"Cocke Travis W.","position":5,"cik":"0001798383","reported_name":"Cocke Travis W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2025-10-28T22:45:45.000Z","date":"2025-10-27","kind":"purchase","planned":false,"acquired":true,"shares":4840,"price":1.3687,"value":6624.508,"ownership":{"direct":false,"nature":"By: Voss Value-Oriented Special Situations Fund, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed jointly by Voss Value Master Fund, LP (\"Voss Value Master Fund\"), Voss Value-Oriented Special Situations Fund, LP (\"Voss Value-Oriented Special Situations Fund\"), Voss Advisors GP, LLC (\"Voss GP\"), Voss Capital, LP (\"Voss Capital\") and Travis W. Cocke (collectively, the \"Reporting Persons\"). Each of the Reporting Persons is a member of a group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, that collectively beneficially owns over 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.3600 to $1.3700, inclusive.\nThe Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities owned directly by Voss Value-Oriented Special Situations Fund. Voss GP, as the general partner of Voss Value-Oriented Special Situations Fund, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund. Voss Capital, as the investment manager of Voss Value-Oriented Special Situations Fund, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value-Oriented Special Situations Fund."}],"balance_after":321608,"source":{"system":"sec-edgar","filing":"0000921895-25-002819","document":"form410925019_10282025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863498/000092189525002819/form410925019_10282025.xml","form_type":"4"}},{"id":1012913,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":18161,"kind":"organization","name":"Voss Capital, LP","position":1,"cik":"0001730145","reported_name":"Voss Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18162,"kind":"organization","name":"Voss Value Master Fund, LP","position":2,"cik":"0001969435","reported_name":"Voss Value Master Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18163,"kind":"organization","name":"Voss Value-Oriented Special Situations Fund, LP","position":3,"cik":"0001863498","reported_name":"Voss Value-Oriented Special Situations Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18164,"kind":"organization","name":"Voss Advisors GP, LLC","position":4,"cik":"0001798309","reported_name":"Voss Advisors GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18165,"kind":"person","name":"Cocke Travis W.","position":5,"cik":"0001798383","reported_name":"Cocke Travis W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2025-10-28T22:45:45.000Z","date":"2025-10-27","kind":"purchase","planned":false,"acquired":true,"shares":92642,"price":1.37,"value":126919.54,"ownership":{"direct":false,"nature":"By: Voss Value Master Fund, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed jointly by Voss Value Master Fund, LP (\"Voss Value Master Fund\"), Voss Value-Oriented Special Situations Fund, LP (\"Voss Value-Oriented Special Situations Fund\"), Voss Advisors GP, LLC (\"Voss GP\"), Voss Capital, LP (\"Voss Capital\") and Travis W. Cocke (collectively, the \"Reporting Persons\"). Each of the Reporting Persons is a member of a group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, that collectively beneficially owns over 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned directly by Voss Value Master Fund. Voss GP, as the general partner of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Voss Capital, as the investment manager of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund."}],"balance_after":822258,"source":{"system":"sec-edgar","filing":"0000921895-25-002819","document":"form410925019_10282025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863498/000092189525002819/form410925019_10282025.xml","form_type":"4"}},{"id":1012912,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":18161,"kind":"organization","name":"Voss Capital, LP","position":1,"cik":"0001730145","reported_name":"Voss Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18162,"kind":"organization","name":"Voss Value Master Fund, LP","position":2,"cik":"0001969435","reported_name":"Voss Value Master Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18163,"kind":"organization","name":"Voss Value-Oriented Special Situations Fund, LP","position":3,"cik":"0001863498","reported_name":"Voss Value-Oriented Special Situations Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18164,"kind":"organization","name":"Voss Advisors GP, LLC","position":4,"cik":"0001798309","reported_name":"Voss Advisors GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18165,"kind":"person","name":"Cocke Travis W.","position":5,"cik":"0001798383","reported_name":"Cocke Travis W.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2025-10-28T22:45:45.000Z","date":"2025-10-24","kind":"purchase","planned":false,"acquired":true,"shares":30176,"price":1.3904,"value":41956.7104,"ownership":{"direct":false,"nature":"By: Voss Value Master Fund, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed jointly by Voss Value Master Fund, LP (\"Voss Value Master Fund\"), Voss Value-Oriented Special Situations Fund, LP (\"Voss Value-Oriented Special Situations Fund\"), Voss Advisors GP, LLC (\"Voss GP\"), Voss Capital, LP (\"Voss Capital\") and Travis W. Cocke (collectively, the \"Reporting Persons\"). Each of the Reporting Persons is a member of a group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, that collectively beneficially owns over 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.3300 to $1.4000, inclusive.\nThe Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities owned directly by Voss Value Master Fund. Voss GP, as the general partner of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Voss Capital, as the investment manager of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund."}],"balance_after":729616,"source":{"system":"sec-edgar","filing":"0000921895-25-002819","document":"form410925019_10282025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863498/000092189525002819/form410925019_10282025.xml","form_type":"4"}},{"id":1082744,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":77285,"kind":"person","name":"Aivado Manuel","position":1,"cik":"0001709603","reported_name":"Aivado Manuel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-23T23:42:24.000Z","date":"2025-07-23","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 23, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) July 23, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":17500,"derivative":{"exercise_price":1.55,"expiration_date":"2035-07-22","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-098046","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017025098046/ownership.xml","form_type":"4"}},{"id":1083029,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-23T23:40:12.000Z","date":"2025-07-23","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 23, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) July 23, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":17500,"derivative":{"exercise_price":1.55,"expiration_date":"2035-07-22","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-098044","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000095017025098044/ownership.xml","form_type":"4"}},{"id":1082743,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-23T23:38:33.000Z","date":"2025-07-23","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 23, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) July 23, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":17500,"derivative":{"exercise_price":1.55,"expiration_date":"2035-07-22","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-098043","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017025098043/ownership.xml","form_type":"4"}},{"id":1082742,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-23T23:37:18.000Z","date":"2025-07-23","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 23, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) July 23, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":17500,"derivative":{"exercise_price":1.55,"expiration_date":"2035-07-22","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-098041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017025098041/ownership.xml","form_type":"4"}},{"id":1082818,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":77290,"kind":"person","name":"Ambros Reinhard J.","position":1,"cik":"0001709690","reported_name":"Ambros Reinhard J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-23T19:36:52.000Z","date":"2025-07-23","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 23, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) July 23, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":17500,"derivative":{"exercise_price":1.55,"expiration_date":"2035-07-22","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-098039","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709690/000095017025098039/ownership.xml","form_type":"4"}},{"id":1338879,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-12-09T21:09:30.000Z","date":"2024-12-05","kind":"purchase","planned":false,"acquired":true,"shares":161,"price":2.25,"value":362.25,"ownership":{"direct":false,"nature":"By son"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":161,"source":{"system":"sec-edgar","filing":"0000950170-24-134522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024134522/ownership.xml","form_type":"4"}},{"id":1338878,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-12-09T21:09:30.000Z","date":"2024-12-05","kind":"purchase","planned":false,"acquired":true,"shares":239,"price":2.24,"value":535.36,"ownership":{"direct":false,"nature":"By son"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":239,"source":{"system":"sec-edgar","filing":"0000950170-24-134522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024134522/ownership.xml","form_type":"4"}},{"id":1340314,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":77285,"kind":"person","name":"Aivado Manuel","position":1,"cik":"0001709603","reported_name":"Aivado Manuel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-06T21:41:02.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 2, 2024. The shares underlying the option are scheduled to vest in full on December 2, 2025."}],"balance_after":35000,"derivative":{"exercise_price":2.85,"expiration_date":"2034-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950170-24-134167","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024134167/ownership.xml","form_type":"4"}},{"id":1340313,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-06T21:35:04.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 2, 2024. The shares underlying the option are scheduled to vest in full on December 2, 2025."}],"balance_after":35000,"derivative":{"exercise_price":2.85,"expiration_date":"2034-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950170-24-134153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024134153/ownership.xml","form_type":"4"}},{"id":1340946,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-06T21:34:58.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 2, 2024. The shares underlying the option are scheduled to vest in full on December 2, 2025."}],"balance_after":35000,"derivative":{"exercise_price":2.85,"expiration_date":"2034-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950170-24-134152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000095017024134152/ownership.xml","form_type":"4"}},{"id":1340312,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-06T21:32:48.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 2, 2024. The shares underlying the option are scheduled to vest in full on December 2, 2025."}],"balance_after":35000,"derivative":{"exercise_price":2.85,"expiration_date":"2034-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950170-24-134145","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024134145/ownership.xml","form_type":"4"}},{"id":1340518,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":77290,"kind":"person","name":"Ambros Reinhard J.","position":1,"cik":"0001709690","reported_name":"Ambros Reinhard J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-06T16:38:23.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 2, 2024. The shares underlying the option are scheduled to vest in full on December 2, 2025."}],"balance_after":35000,"derivative":{"exercise_price":2.85,"expiration_date":"2034-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950170-24-134160","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709690/000095017024134160/ownership.xml","form_type":"4"}},{"id":1342765,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-04T21:05:08.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":517500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 2, 2024. The shares underlying the option are scheduled to vest as of 25% of the shares on December 2, 2025 and thereafter in equal monthly installments through December 2, 2028."}],"balance_after":517500,"derivative":{"exercise_price":2.85,"expiration_date":"2034-12-01","underlying":"Common Stock","underlying_shares":517500},"source":{"system":"sec-edgar","filing":"0000950170-24-133231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024133231/ownership.xml","form_type":"4"}},{"id":1425183,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":77285,"kind":"person","name":"Aivado Manuel","position":1,"cik":"0001709603","reported_name":"Aivado Manuel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-22T20:09:02.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 20, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) August 20, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":2.4,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-099840","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024099840/ownership.xml","form_type":"4"}},{"id":1425895,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-22T20:07:24.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 20, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) August 20, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":2.4,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-099838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000095017024099838/ownership.xml","form_type":"4"}},{"id":1425182,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-22T20:06:55.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 20, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) August 20, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":2.4,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-099837","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024099837/ownership.xml","form_type":"4"}},{"id":1425181,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-22T20:05:58.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 20, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) August 20, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":2.4,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-099833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024099833/ownership.xml","form_type":"4"}},{"id":1425353,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":77290,"kind":"person","name":"Ambros Reinhard J.","position":1,"cik":"0001709690","reported_name":"Ambros Reinhard J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-22T16:06:16.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 20, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) August 20, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":2.4,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-099834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709690/000095017024099834/ownership.xml","form_type":"4"}},{"id":1477903,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-17T23:03:29.000Z","date":"2024-06-17","kind":"sale","planned":false,"acquired":false,"shares":4707,"price":3.25,"value":15297.75,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1746549,"source":{"system":"sec-edgar","filing":"0001019231-24-000026","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000026/primary_doc.xml","form_type":"4"}},{"id":1477902,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-17T23:03:29.000Z","date":"2024-06-14","kind":"sale","planned":false,"acquired":false,"shares":1900,"price":3.3,"value":6270.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1751256,"source":{"system":"sec-edgar","filing":"0001019231-24-000026","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000026/primary_doc.xml","form_type":"4"}},{"id":1482489,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T22:18:42.000Z","date":"2024-06-12","kind":"sale","planned":false,"acquired":false,"shares":1,"price":3.275,"value":3.275,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1753156,"source":{"system":"sec-edgar","filing":"0001019231-24-000025","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000025/primary_doc.xml","form_type":"4"}},{"id":1482488,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T22:18:42.000Z","date":"2024-06-12","kind":"sale","planned":false,"acquired":false,"shares":9341,"price":3.25,"value":30358.25,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1753157,"source":{"system":"sec-edgar","filing":"0001019231-24-000025","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000025/primary_doc.xml","form_type":"4"}},{"id":1482487,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T22:18:42.000Z","date":"2024-06-11","kind":"sale","planned":false,"acquired":false,"shares":502,"price":3.35,"value":1681.7,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1762498,"source":{"system":"sec-edgar","filing":"0001019231-24-000025","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000025/primary_doc.xml","form_type":"4"}},{"id":1482486,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T22:18:42.000Z","date":"2024-06-11","kind":"sale","planned":false,"acquired":false,"shares":5250,"price":3.25,"value":17062.5,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1763000,"source":{"system":"sec-edgar","filing":"0001019231-24-000025","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000025/primary_doc.xml","form_type":"4"}},{"id":1482485,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T22:18:42.000Z","date":"2024-06-10","kind":"sale","planned":false,"acquired":false,"shares":9577,"price":3.3,"value":31604.1,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1768250,"source":{"system":"sec-edgar","filing":"0001019231-24-000025","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000025/primary_doc.xml","form_type":"4"}},{"id":1487504,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T22:59:09.000Z","date":"2024-06-07","kind":"sale","planned":false,"acquired":false,"shares":176,"price":3.3,"value":580.8,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1777827,"source":{"system":"sec-edgar","filing":"0001019231-24-000024","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000024/primary_doc.xml","form_type":"4"}},{"id":1487503,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T22:59:09.000Z","date":"2024-06-07","kind":"sale","planned":false,"acquired":false,"shares":1564,"price":3.25,"value":5083.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1778003,"source":{"system":"sec-edgar","filing":"0001019231-24-000024","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000024/primary_doc.xml","form_type":"4"}},{"id":1487502,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T22:59:09.000Z","date":"2024-06-06","kind":"sale","planned":false,"acquired":false,"shares":3184,"price":3.3,"value":10507.2,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1779567,"source":{"system":"sec-edgar","filing":"0001019231-24-000024","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000024/primary_doc.xml","form_type":"4"}},{"id":1487501,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T22:59:09.000Z","date":"2024-06-06","kind":"sale","planned":false,"acquired":false,"shares":1100,"price":3.27,"value":3597.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1782751,"source":{"system":"sec-edgar","filing":"0001019231-24-000024","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000024/primary_doc.xml","form_type":"4"}},{"id":1487500,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T22:59:09.000Z","date":"2024-06-05","kind":"sale","planned":false,"acquired":false,"shares":6291,"price":3.3,"value":20760.3,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1783851,"source":{"system":"sec-edgar","filing":"0001019231-24-000024","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000024/primary_doc.xml","form_type":"4"}},{"id":1518050,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":25,"price":4.32,"value":108.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1790142,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518049,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":2903,"price":4.29,"value":12453.87,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1790167,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518048,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":200,"price":4.285,"value":857.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1793070,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518047,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":337,"price":4.28,"value":1442.36,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1793270,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518046,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":200,"price":4.275,"value":855.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1793607,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518045,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":100,"price":4.27,"value":427.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1793807,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518044,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":317,"price":4.265,"value":1352.005,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1793907,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518043,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":310,"price":4.26,"value":1320.6,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1794224,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518042,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":7923,"price":4.25,"value":33672.75,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1794534,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518041,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":400,"price":4.18,"value":1672.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1802457,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518040,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":670,"price":4.15,"value":2780.5,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1802857,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518039,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":1600,"price":4.145,"value":6632.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1803527,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518038,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":380,"price":4.13,"value":1569.4,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1805127,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518037,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":1750,"price":4.12,"value":7210.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1805507,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518036,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":100,"price":4.11,"value":411.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1807257,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1518035,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:54:05.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":3100,"price":4.1,"value":12710.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1807357,"source":{"system":"sec-edgar","filing":"0001019231-24-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000023/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-05-01"}},{"id":1532317,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":25,"price":4.32,"value":108.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1779306,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532316,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":2903,"price":4.29,"value":12453.87,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1779331,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532315,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":200,"price":4.285,"value":857.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1782234,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532314,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":337,"price":4.28,"value":1442.36,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1782434,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532313,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":200,"price":4.275,"value":855.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1782771,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532312,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":100,"price":4.27,"value":427.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1782971,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532311,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":317,"price":4.265,"value":1352.005,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1783071,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532310,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":310,"price":4.26,"value":1320.6,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1783388,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532309,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":7923,"price":4.25,"value":33672.75,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1783698,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532308,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":400,"price":4.18,"value":1672.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1791621,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532307,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":670,"price":4.15,"value":2780.5,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1792021,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532306,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":1600,"price":4.145,"value":6632.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1792691,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532305,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":380,"price":4.13,"value":1569.4,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1794291,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532304,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":1750,"price":4.12,"value":7210.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1794671,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532303,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":100,"price":4.11,"value":411.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1796421,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532302,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":3100,"price":4.1,"value":12710.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1796521,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532301,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-04-30","kind":"sale","planned":false,"acquired":false,"shares":45,"price":5,"value":225.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1799621,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532300,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-04-30","kind":"sale","planned":false,"acquired":false,"shares":45,"price":4.95,"value":222.75,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1799666,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532299,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-04-29","kind":"sale","planned":false,"acquired":false,"shares":448,"price":5.025,"value":2251.2,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1799711,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532298,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-04-29","kind":"sale","planned":false,"acquired":false,"shares":13,"price":5.005,"value":65.065,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1800159,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532297,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-04-29","kind":"sale","planned":false,"acquired":false,"shares":3231,"price":5,"value":16155.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1800172,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532296,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-04-29","kind":"sale","planned":false,"acquired":false,"shares":100,"price":4.94,"value":494.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1803403,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532295,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-04-29","kind":"sale","planned":false,"acquired":false,"shares":274,"price":4.93,"value":1350.82,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1803503,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1532294,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43279,"kind":"organization","name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","position":1,"cik":"0001019231","reported_name":"UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-01T23:15:42.000Z","date":"2024-04-29","kind":"sale","planned":false,"acquired":false,"shares":6680,"price":4.92,"value":32865.6,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the \"Regents\"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents."}],"balance_after":1803777,"source":{"system":"sec-edgar","filing":"0001019231-24-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1019231/000101923124000022/primary_doc.xml","form_type":"4"}},{"id":1544021,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-10T20:15:09.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 28, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) February 28, 2025 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":4.72,"expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-043362","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000095017024043362/ownership.xml","form_type":"4/A","original_submission_date":"2024-03-01"}},{"id":1543827,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":77290,"kind":"person","name":"Ambros Reinhard J.","position":1,"cik":"0001709690","reported_name":"Ambros Reinhard J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-10T16:15:05.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 28, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) February 28, 2025 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":4.72,"expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-043361","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709690/000095017024043361/ownership.xml","form_type":"4/A","original_submission_date":"2024-03-01"}},{"id":1591408,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Series X Non-Voting Convertible Preferred","published_at":"2024-03-06T22:06:15.000Z","date":"2024-03-05","kind":"exercise","planned":false,"acquired":false,"shares":2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 5, 2024, the Issuer's outstanding Series X Non-Voting Convertible Preferred Stock, par value $0.001 per share (\"Series X Preferred Stock\") automatically converted into shares of common stock of the Issuer, par value $0.001 per share (\"Common Stock\"), subject to certain beneficial ownership limitations. By operation of the certificate of designation for the Series X Preferred Stock, each share of Series X Preferred Stock was converted into 1,000 shares of Common Stock for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 5, 2024, the Issuer's outstanding Series X Non-Voting Convertible Preferred Stock, par value $0.001 per share (\"Series X Preferred Stock\") automatically converted into shares of common stock of the Issuer, par value $0.001 per share (\"Common Stock\"), subject to certain beneficial ownership limitations. By operation of the certificate of designation for the Series X Preferred Stock, each share of Series X Preferred Stock was converted into 1,000 shares of Common Stock for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 5, 2024, the Issuer's outstanding Series X Non-Voting Convertible Preferred Stock, par value $0.001 per share (\"Series X Preferred Stock\") automatically converted into shares of common stock of the Issuer, par value $0.001 per share (\"Common Stock\"), subject to certain beneficial ownership limitations. By operation of the certificate of designation for the Series X Preferred Stock, each share of Series X Preferred Stock was converted into 1,000 shares of Common Stock for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 5, 2024, the Issuer's outstanding Series X Non-Voting Convertible Preferred Stock, par value $0.001 per share (\"Series X Preferred Stock\") automatically converted into shares of common stock of the Issuer, par value $0.001 per share (\"Common Stock\"), subject to certain beneficial ownership limitations. By operation of the certificate of designation for the Series X Preferred Stock, each share of Series X Preferred Stock was converted into 1,000 shares of Common Stock for no consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000950170-24-027304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024027304/ownership.xml","form_type":"4"}},{"id":1591407,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-03-06T22:06:15.000Z","date":"2024-03-05","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 5, 2024, the Issuer's outstanding Series X Non-Voting Convertible Preferred Stock, par value $0.001 per share (\"Series X Preferred Stock\") automatically converted into shares of common stock of the Issuer, par value $0.001 per share (\"Common Stock\"), subject to certain beneficial ownership limitations. By operation of the certificate of designation for the Series X Preferred Stock, each share of Series X Preferred Stock was converted into 1,000 shares of Common Stock for no consideration."}],"balance_after":7122,"source":{"system":"sec-edgar","filing":"0000950170-24-027304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024027304/ownership.xml","form_type":"4"}},{"id":1608251,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T21:05:34.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 28, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) February 28, 2025 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":4.8,"expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-023839","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000095017024023839/ownership.xml","form_type":"4"}},{"id":1607151,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":77290,"kind":"person","name":"Ambros Reinhard J.","position":1,"cik":"0001709690","reported_name":"Ambros Reinhard J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T16:05:35.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 28, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) February 28, 2025 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":4.8,"expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-023840","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709690/000095017024023840/ownership.xml","form_type":"4"}},{"id":1706993,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-12-18T22:56:31.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":225,"price":3.37,"value":758.25,"ownership":{"direct":false,"nature":"By son"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose"}],"balance_after":225,"source":{"system":"sec-edgar","filing":"0000950170-23-071200","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017023071200/ownership.xml","form_type":"4"}},{"id":1732496,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-11-21T21:43:12.000Z","date":"2023-11-20","kind":"purchase","planned":false,"acquired":true,"shares":5076,"price":1.9675,"value":9987.03,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.965 - $1.9699. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":5122,"source":{"system":"sec-edgar","filing":"0000950170-23-065545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017023065545/ownership.xml","form_type":"4"}},{"id":1751195,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-03T00:55:22.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":5450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted October 31, 2023. The shares underlying the option are scheduled to vest over 48 equal monthly installments from October 31, 2023, subject to continued service."}],"balance_after":5450,"derivative":{"exercise_price":1.17,"expiration_date":"2033-10-30","underlying":"Common Stock","underlying_shares":5450},"source":{"system":"sec-edgar","filing":"0000899243-23-020117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924323020117/doc4.xml","form_type":"4"}},{"id":1751194,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-03T00:53:07.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":5450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 31, 2023. The shares underlying the option are scheduled to vest over 48 equal monthly installments from October 31, 2023, subject to continued service."}],"balance_after":5450,"derivative":{"exercise_price":1.17,"expiration_date":"2033-10-30","underlying":"Common Stock","underlying_shares":5450},"source":{"system":"sec-edgar","filing":"0000899243-23-020116","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924323020116/doc4.xml","form_type":"4"}},{"id":2227804,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":19080,"kind":"person","name":"Morrison Jodie Pope","position":1,"cik":"0001618247","reported_name":"Morrison Jodie Pope","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T21:22:19.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":54500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":54500,"derivative":{"exercise_price":0.397,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":54500},"source":{"system":"sec-edgar","filing":"0000899243-22-023148","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618247/000089924322023148/doc4.xml","form_type":"4"}},{"id":2227487,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T21:18:27.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":54500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":54500,"derivative":{"exercise_price":0.397,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":54500},"source":{"system":"sec-edgar","filing":"0000899243-22-023146","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924322023146/doc4.xml","form_type":"4"}},{"id":2228709,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T21:16:13.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":54500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":54500,"derivative":{"exercise_price":0.397,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":54500},"source":{"system":"sec-edgar","filing":"0000899243-22-023144","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000089924322023144/doc4.xml","form_type":"4"}},{"id":2227486,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":126045,"kind":"person","name":"Sigal Nolan Howard","position":1,"cik":"0001323291","reported_name":"Sigal Nolan Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T21:12:32.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":54500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":54500,"derivative":{"exercise_price":0.397,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":54500},"source":{"system":"sec-edgar","filing":"0000899243-22-023139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924322023139/doc4.xml","form_type":"4"}},{"id":2227762,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T21:10:49.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":54500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":54500,"derivative":{"exercise_price":0.397,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":54500},"source":{"system":"sec-edgar","filing":"0000899243-22-023133","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000089924322023133/doc4.xml","form_type":"4"}},{"id":2227983,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":77290,"kind":"person","name":"Ambros Reinhard J.","position":1,"cik":"0001709690","reported_name":"Ambros Reinhard J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T17:12:00.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":54500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":54500,"derivative":{"exercise_price":0.397,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":54500},"source":{"system":"sec-edgar","filing":"0000899243-22-023136","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709690/000089924322023136/doc4.xml","form_type":"4"}},{"id":2314124,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":77285,"kind":"person","name":"Aivado Manuel","position":1,"cik":"0001709603","reported_name":"Aivado Manuel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-31T00:33:52.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":1133000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This amendment is being filed to correct the date of grant and the exercise price for the stock option reported on a Form 4 filed by the reporting person on March 24, 2022. This option became effective on March 30, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option are scheduled to vest in equal monthly installments through March 30, 2026."}],"balance_after":1133000,"derivative":{"exercise_price":0.48,"expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":1133000},"source":{"system":"sec-edgar","filing":"0000899243-22-012858","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924322012858/doc4a.xml","form_type":"4/A","original_submission_date":"2022-03-24"}},{"id":2314122,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":126931,"kind":"person","name":"Wanstall Rick","position":1,"cik":"0001771222","reported_name":"Wanstall Rick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-31T00:32:10.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":393000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This amendment is being filed to correct the date of grant and the exercise price for the stock option reported on a Form 4 filed by the reporting person on March 24, 2022. This option became effective on March 30, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option are scheduled to vest in equal monthly installments through March 30, 2026."}],"balance_after":393000,"derivative":{"exercise_price":0.48,"expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":393000},"source":{"system":"sec-edgar","filing":"0000899243-22-012856","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924322012856/doc4a.xml","form_type":"4/A","original_submission_date":"2022-03-24"}},{"id":2314150,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-30T20:32:28.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This amendment is being filed to correct the date of grant and the exercise price for the stock option reported on a Form 4 filed by the reporting person on March 24, 2022. This option became effective on March 30, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option are scheduled to vest in equal monthly installments through March 30, 2026."}],"balance_after":150000,"derivative":{"exercise_price":0.48,"expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-22-012857","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466794/000089924322012857/doc4a.xml","form_type":"4/A","original_submission_date":"2022-03-24"}}],"next_cursor":"2022-03-30T20:32:28.000000Z,2314150"}